282 related articles for article (PubMed ID: 24397165)
1. [Cardiovascular event in elderly patients with diabetes mellitus].
Nomura K
Nihon Rinsho; 2013 Nov; 71(11):1954-9. PubMed ID: 24397165
[TBL] [Abstract][Full Text] [Related]
2. Diabetes mellitus: a cardiovascular disease.
Candido R; Srivastava P; Cooper ME; Burrell LM
Curr Opin Investig Drugs; 2003 Sep; 4(9):1088-94. PubMed ID: 14582453
[TBL] [Abstract][Full Text] [Related]
3. Early and intensive therapy for management of hyperglycemia and cardiovascular risk factors in patients with type 2 diabetes.
Dailey G
Clin Ther; 2011 Jun; 33(6):665-78. PubMed ID: 21704233
[TBL] [Abstract][Full Text] [Related]
4. Does intensive glycemic control improve cardiovascular outcomes?
Pendergrass M
Nat Clin Pract Endocrinol Metab; 2008 Oct; 4(10):529. PubMed ID: 18806805
[No Abstract] [Full Text] [Related]
5. [The polypill: optimal strategy for reduction of cardiovascular disease].
Nathoe HM; Doevendans PA
Ned Tijdschr Geneeskd; 2005 Jul; 149(31):1740. PubMed ID: 16114290
[TBL] [Abstract][Full Text] [Related]
6. Treating the diabetic patient: appropriate care for glycemic control and cardiovascular disease risk factors.
Zarich SW
Rev Cardiovasc Med; 2003; 4 Suppl 6():S19-28. PubMed ID: 14668700
[TBL] [Abstract][Full Text] [Related]
7. Attenuating cardiovascular risk factors in patients with type 2 diabetes.
Garber AJ
Am Fam Physician; 2000 Dec; 62(12):2633-42, 2645-6. PubMed ID: 11142470
[TBL] [Abstract][Full Text] [Related]
8. [Management of diabetes in cardiac diseases].
Işik S; Delibaşi T; Berker D; Aydin Y; Güler S
Anadolu Kardiyol Derg; 2009 Jun; 9(3):238-47. PubMed ID: 19520659
[TBL] [Abstract][Full Text] [Related]
9. Pharmacologic prevention of microvascular and macrovascular complications in diabetes mellitus: implications of the results of recent clinical trials in type 2 diabetes.
Tandon N; Ali MK; Narayan KM
Am J Cardiovasc Drugs; 2012 Feb; 12(1):7-22. PubMed ID: 22217193
[TBL] [Abstract][Full Text] [Related]
10. Reducing CV risk in diabetes: An ADA update.
Skolnik N; Jaffa FM; Kalyani RR; Johnson E; Shubrook JH
J Fam Pract; 2017 May; 66(5):300-308. PubMed ID: 28459890
[TBL] [Abstract][Full Text] [Related]
11. [Practical prevention and treatment of cardiovascular diseases in patients with diabetes mellitus type 2 in an endocrinological department].
Daurbekova LV; Orlov VA; Giliarevskiĭ SR; Abirova ES; Murzabekova LI
Ter Arkh; 2004; 76(12):32-6. PubMed ID: 15724922
[TBL] [Abstract][Full Text] [Related]
12. [Intensified treatment of type 2 diabetes mellitus. Is polypharmacy necessary and justified?].
Pedersen OB; Gaede PH
Ugeskr Laeger; 2000 Jun; 162(25):3582-91. PubMed ID: 11016281
[TBL] [Abstract][Full Text] [Related]
13. [Overview of drug therapy in elderly diabetic patients].
Kigawa Y; Suzuki T; Oba K
Nihon Rinsho; 2013 Nov; 71(11):1982-6. PubMed ID: 24397170
[TBL] [Abstract][Full Text] [Related]
14. Improving the adverse cardiovascular prognosis of type 2 diabetes.
O'Keefe JH; Miles JM; Harris WH; Moe RM; McCallister BD
Mayo Clin Proc; 1999 Feb; 74(2):171-80. PubMed ID: 10069357
[TBL] [Abstract][Full Text] [Related]
15. Outcome studies in type 2 diabetes.
Hanefeld M
Curr Med Res Opin; 2005; 21 Suppl 1():S41-8. PubMed ID: 15811198
[TBL] [Abstract][Full Text] [Related]
16. Diabetes and heart disease an evidence-driven guide to risk factors management in diabetes.
Lteif AA; Mather KJ; Clark CM
Cardiol Rev; 2003; 11(5):262-74. PubMed ID: 12943604
[TBL] [Abstract][Full Text] [Related]
17. [Prevention of cardiovascular disease in type 2 diabetic patients].
Yokota C
Nihon Rinsho; 2003 Jul; 61(7):1161-6. PubMed ID: 12877078
[TBL] [Abstract][Full Text] [Related]
18. Suboptimal use of cardioprotective drugs in newly treated elderly individuals with type 2 diabetes.
Sirois C; Moisan J; Poirier P; Grégoire JP
Diabetes Care; 2007 Jul; 30(7):1880-2. PubMed ID: 17384345
[No Abstract] [Full Text] [Related]
19. The Polypill in the prevention of cardiovascular disease.
Wald DS; Wald NJ
Prev Med; 2011 Jan; 52(1):16-7. PubMed ID: 21130112
[No Abstract] [Full Text] [Related]
20. [The polypill: not an effective strategy for reduction of cardiovascular disease].
Westerweel PE; van Wijk JP; Verhaar MC
Ned Tijdschr Geneeskd; 2005 Jul; 149(31):1741. PubMed ID: 16114291
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
